COVID-19 vaccine safety report (17 November 2022)

17 November 2022 - To 13 November 2022, the TGA has received 706 reports which have been assessed as likely to ...

Read more →

Novavax’s COVID-19 booster has been approved for adults, Health Canada says

17 November 2022 - Health Canada said Thursday it has approved the booster dose of Novavax‘s Nuvaxovid COVID-19 vaccine for ...

Read more →

New COVID-19 vaccines for eligible Australians

15 November 2022 - The Australian Government has accepted a recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) on ...

Read more →

This is how access to older antibiotics can be strengthened

14 November 2022 - Shortages in access to antibiotics can pose serious obstacles to responsible antibiotic treatment - and a survey ...

Read more →

ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years

15 November 2022 - On 29 September 2022, the TGA provisionally approved Comirnaty (Pfizer) COVID-19 vaccine for use in children ...

Read more →

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine

15 November 2022 - On 27 October 2022, the TGA provisionally approved the Pfizer (Comirnaty) Bivalent Original/Omicron BA.1 vaccine (subsequently referred ...

Read more →

ATAGI update on boosters following COVID-19 meeting on 11 November 2022

15 November 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their meeting on 11 November ...

Read more →

COVID-19 vaccine safety report (3 November 2022)

3 November 2022 - To 30 October 2022, the TGA has received 704 reports which have been assessed as likely to ...

Read more →

New COVID-19 variant leads to increase in cases

8 November 2022 - A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, on the increase in COVID-19 cases ...

Read more →

The Australian Government is committed to ensuring the safety of those at risk of monkeypox and has been working closely with states, territories and key stakeholders to ensure a coordinated national response

7 November 2022 - The Australian Government is committed to ensuring the safety of those at risk of monkeypox and ...

Read more →

PHARMAC considers funding meningococcal B vaccine to be part of childhood immunisations

26 October 2022 - PHARMAC today has announced a consultation on widening access to the meningococcal B vaccine (branded as Bexsero), ...

Read more →

ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years

24 October 2022 - Recommendations from the Australian Technical Advisory Group on Immunisation on Pfizer booster doses for children aged 5 ...

Read more →

COVID-19 vaccine safety report (20 October 2022)

20 October 2022 - To 16 October 2022, the TGA has received 705 reports which have been assessed as likely to ...

Read more →

Clarity around PHARMAC’s priority lists (October 2022)

13 October 2022 - In March 2022, PHARMAC released its first Pūahoaho (clarity) Report, containing the latest information about its ...

Read more →

Monkeypox vaccine not expected in NZ until December as community spread confirmed

10 October 2022 - New Zealand now has community transmission of monkeypox, but a vaccine to protect those at highest ...

Read more →